ACTRN12607000431426: A Phase 1, open label, repeat-dose, dose escalation study of the safety and tolerability of Staphylococcal protein A in adult patients with chronic Idiopathic Thrombocytopenic Purpura (ITP) |
|
|
| Recruiting | 1 | 21 | | | Protalex, Inc., Protalex, Inc. | Idiopathic Thrombocytopenic Purpura | | | | |